ABBV position history
The shares of AbbVie (ABBV) that Murphy Pohlad Asset Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 2,124 shares, $229K, 0.09% of portfolio
- 2021 Q4: 2,124 shares, $287K, 0.11% of portfolio
- 2022 Q1: 2,124 shares, $344K, 0.14% of portfolio
- 2022 Q2: 2,124 shares, $325K, 0.14% of portfolio
- 2022 Q3: 2,143 shares, $287K, 0.13% of portfolio, Add +0.9%
- 2022 Q4: 2,035 shares, $329K, 0.13% of portfolio, Reduce −5.0%
- 2023 Q1: 1,860 shares, $296K, 0.12% of portfolio, Reduce −8.6%
- 2023 Q2: 1,785 shares, $240K, 0.10% of portfolio, Reduce −4.0%
- 2023 Q3: 1,785 shares, $266K, 0.12% of portfolio
- 2023 Q4: 1,835 shares, $284K, 0.12% of portfolio, Add +2.8%
- 2024 Q1: 1,785 shares, $325K, 0.13% of portfolio, Reduce −2.7%
- 2024 Q2: 1,775 shares, $304K, 0.13% of portfolio, Reduce −0.6%
- 2024 Q3: 1,581 shares, $312K, 0.13% of portfolio, Reduce −10.9%
- 2024 Q4: 1,581 shares, $281K, 0.12% of portfolio
- 2025 Q1: 3,849 shares, $806K, 0.34% of portfolio, Add +143.5%
- 2025 Q2: 3,849 shares, $714K, 0.30% of portfolio
- 2025 Q3: 3,849 shares, $891K, 0.35% of portfolio
- 2025 Q4: 3,849 shares, $879K, 0.34% of portfolio
- 2026 Q1: 3,634 shares, $790K, 0.28% of portfolio, Reduce −5.6%
- 2026 Q2: 3,594 shares, $904K, 0.31% of portfolio, Reduce −1.1%
- 2026 Q3: 3,286 shares, $860K, 0.30% of portfolio, Reduce −8.6%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|